GlassScriptPhysician profile
Andrew A Brief
NPI 1841206653
$253,186.08
in general payments reported to CMS, 2019-2025
23 companies · $26K in 2025
The $26K reported for 2025 was more than what 87% of Foot and Ankle Surgery providers received nationally (typical 2025 total: $1,200).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $47K · 2020: $23K · 2021: $27K · 2022: $90K · 2023: $29K · 2024: $12K · 2025: $26K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $61K · Food and Beverage: $3,176 · Travel and Lodging: $1,281 · Consulting Fee: $1,250.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $60,854.70 |
| Food and Beverage | $3,176.07 |
| Travel and Lodging | $1,280.52 |
| Consulting Fee | $1,250.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medartis INC. | $96,291.21 | 2022-2025 | Aptus |
| Extremity Medical | $76,694.90 | 2019-2025 | Omni |
| Nextremity Solutions INC. | $67,491.01 | 2019-2021 | |
| Seapearl East, INC | $3,206.12 | 2019-2025 | |
| Synthes USA Products LLC | $2,882.50 | 2021 | |
| Stryker Corporation | $2,724.09 | 2019-2025 | Gamma, Citrefix, Inbone |
| Arthrex, INC. | $1,144.40 | 2020-2023 | |
| Bioventus LLC | $924.49 | 2019-2025 | Durolane, Exogen Ultrasound Bone Healing System |
| Depuy Synthes Sales INC. | $319.26 | 2020-2025 | Monovisc |
| Wright Medical Technology, INC. | $312.45 | 2019 | |
| Kerecis Limited | $310.97 | 2023-2025 | Kerecis Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Arteriocyte Medical Systems, INC. | $284.26 | 2023-2024 | Magellan |
| Biocomposites INC | $149.70 | 2025 | Stimulan |
| Paragon 28, INC. | $131.33 | 2025 | R3flex |
| Fusion Orthopedics USA, LLC | $128.10 | 2025 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Solventum Corporation | $39.83 | 2025 | Prevena |
| Pacira Pharmaceuticals Incorporated | $26.90 | 2022-2025 | Exparel |
| Kci USA, INC. | $26.30 | 2020 | |
| Integra Lifesciences Corporation | $26.21 | 2019 | |
| Axogen | $24.97 | 2019 | |
| Smith+Nephew, INC. | $23.71 | 2025 | Pico 14 |
| Cumberland Pharmaceuticals, INC. | $12.05 | 2019 | |
| Merck Sharp & Dohme LLC | $11.32 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Brief listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.